Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

Stanford Hospital nurses preparing to call strike

Three days of federal mediation failed to produce a deal with hospital administrators.

To control costs, it may be up to patients to 'pay the piper'

After many seemingly “routine” doctor’s appointments, many Americans receive their bill and try to make sense of the many ins-and-outs of deductibles, co-pays, reimbursement rules, and paperwork. They face a whirlwind of complexities that have nothing to do with buying healthcare.

Arkansas governor uses veto to save Medicaid program

Gov. Asa Hutchinson of Arkansas vetoed part of a Medicaid budget bill that that would have ended the subsidized insurance for more than 250,000 people, saving the first-in-the-nation hybrid Medicaid expansion.

Oklahoma legislation would strip licenses of doctors who perform abortions

State legislators have passed a bill which would define performing an abortion as “unprofessional conduct” by a physician.

NIH Clinical Center needs reforms to emphasize patient safety over research, panel says

Safety standards and oversight need to be overhauled, according to an agency-appointed task force.

JAMA seeking gun violence studies

The American Medical Association’s internal medicine journal is asking for papers on gun violence and firearm injuries.

Audiologists facing stiffer competition from consumer electronics on hearing aids

People affected by hearing loss are increasingly turning to devices found at electronics stores, rather than going through an audiologist.  

Demographics of patients shift as Federally Qualified Health Centers expand

In a report published by JAMA Internal Medicine, it was found that the demographics of patients seen at Federally Qualified Health Centers (FQHCs) from 2005 and 2014 have shifted to where the population of young, low-income, uninsured or Medicaid-insured, racial and ethnic minority Americans increased more rapidly than other demographic groups.

Around the web

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Trimed Popup
Trimed Popup